Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation
Keywords: Adjuvant therapy; Nexrutine; Prostate cancer; Radiotherapy; RPS6KB1; TRAMP; Natural products;